MX2022010391A - Metodo de preparacion de derivados de amina heterociclica. - Google Patents

Metodo de preparacion de derivados de amina heterociclica.

Info

Publication number
MX2022010391A
MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A
Authority
MX
Mexico
Prior art keywords
heterocyclicamine
derivatives
preparation
present
prepared
Prior art date
Application number
MX2022010391A
Other languages
English (en)
Inventor
Deok Ki Eom
Joon Seok Park
Qing Ri Li
Wol Young Kim
Hyae Jung Hyun
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020210025655A external-priority patent/KR102531088B1/ko
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of MX2022010391A publication Critical patent/MX2022010391A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente divulgación se refiere a un método para preparar un derivado de amina heterocíclica, y el método de preparación según la presente divulgación tiene la ventaja de que puede prepararse un derivado de amina heterocíclica que tiene un contenido de impurezas reducido con un alto rendimiento.
MX2022010391A 2020-02-26 2021-02-26 Metodo de preparacion de derivados de amina heterociclica. MX2022010391A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20200023899 2020-02-26
KR1020210025655A KR102531088B1 (ko) 2020-02-26 2021-02-25 헤테로사이클릭아민 유도체의 제조 방법
PCT/KR2021/002440 WO2021172922A1 (ko) 2020-02-26 2021-02-26 헤테로사이클릭아민 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
MX2022010391A true MX2022010391A (es) 2022-09-05

Family

ID=77490106

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010391A MX2022010391A (es) 2020-02-26 2021-02-26 Metodo de preparacion de derivados de amina heterociclica.

Country Status (9)

Country Link
US (1) US20230094404A1 (es)
EP (1) EP4112617A4 (es)
JP (1) JP7447291B2 (es)
CN (1) CN115151537B (es)
BR (1) BR112022016729A2 (es)
CO (1) CO2022011593A2 (es)
JO (1) JOP20220199A1 (es)
MX (1) MX2022010391A (es)
WO (1) WO2021172922A1 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318812T1 (de) 2000-12-21 2006-03-15 Bristol Myers Squibb Co Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
WO2005056785A2 (en) 2003-12-05 2005-06-23 Vertex Pharmaceuticals, Inc. Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof
WO2005066335A1 (en) 2003-12-30 2005-07-21 Boehringer Ingelheim Pharmaceuticals, Inc. Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain
EP2532235A1 (en) 2006-09-22 2012-12-12 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
WO2012035055A1 (en) * 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
WO2014036016A1 (en) 2012-08-31 2014-03-06 Principia Biopharma Inc. Benzimidazole derivatives as itk inhibitors
WO2014055934A2 (en) 2012-10-04 2014-04-10 University Of Utah Research Foundation Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
WO2015061247A2 (en) 2013-10-21 2015-04-30 Merck Patent Gmbh Heteroaryl compounds as btk inhibitors and uses thereof
CN104628657A (zh) * 2013-11-06 2015-05-20 韩冰 一类治疗缺血性脑损伤的化合物及其用途
EP3715346B1 (en) * 2014-10-22 2024-01-03 Dana-Farber Cancer Institute, Inc. Thiazolyl-containing compounds for treating proliferative diseases
KR102613433B1 (ko) * 2017-10-11 2023-12-13 주식회사 대웅제약 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물
KR102328682B1 (ko) * 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Also Published As

Publication number Publication date
JOP20220199A1 (ar) 2023-01-30
US20230094404A1 (en) 2023-03-30
JP2023515197A (ja) 2023-04-12
BR112022016729A2 (pt) 2022-10-11
CO2022011593A2 (es) 2022-08-30
EP4112617A4 (en) 2024-03-13
CN115151537B (zh) 2024-09-06
JP7447291B2 (ja) 2024-03-11
CN115151537A (zh) 2022-10-04
EP4112617A1 (en) 2023-01-04
WO2021172922A1 (ko) 2021-09-02

Similar Documents

Publication Publication Date Title
PH12018500093A1 (en) Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PH12019500493A1 (en) Solvate form of (r)-2-amino-3-phenylpropyl carbamate
MX2015016947A (es) Metodos para producir derivados de acido graso omega-hidroxilados.
MY197904A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
EA201992873A1 (ru) Получение фосфатных производных
EA202191502A1 (ru) Способ получения апиксабана
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
MX2022015151A (es) Procesos para preparar acido 3-(3-(3,5-dimetil-1h-pirazol-4-il)pro poxi)-4- 5-fluorobenzoico (ag-10), sus compuestos intermedios, y sales del mismo.
MY178759A (en) Method for preparing trichlorosilane
PH12019502638A1 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
NZ749715A (en) Leuconostoc mesenteroides cjlm119 strain producing reduced amount of gas, and kimchi production method using same
MX2020006040A (es) Intermedios para derivados de piperidina opticamente activos y procedimientos de preparacion de los mismos.
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
MX2022010391A (es) Metodo de preparacion de derivados de amina heterociclica.
IL279168B (en) A process for the preparation of eribulin
MY165659A (en) Novel method of preparing benzoimidazole derivatives
WO2018196883A3 (zh) 一种16β-甲基甾族化合物的制备方法
MX2024001304A (es) Composiciones y metodos para anticuerpos anti-pacap.
EA200870320A1 (ru) Способ получения г-ксф человека
MX2023005954A (es) Procesos para preparar citrato de arimoclomol e intermediarios del mismo.
WO2019215753A3 (en) Process for preparation of pure plecanatide
WO2016079757A3 (en) NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXYMETHYL-OXAZOLIDINE-2-ONE
MX2022004935A (es) (+)- trans tetrahidrocannabinol ((+)-trans-thc) para uso como medicamento.
MX2024004579A (es) Metodo de preparacion de derivado de benzofurano.
IN2014DE00737A (es)